1. Articles in category: Other Business News

    937-960 of 1027 « 1 2 ... 37 38 39 40 41 42 43 »
    1. Pioneering technology can detect glaucoma

      There are only about 30 OCT machines across the country and waiting for a hospital appointment to use the machine can be time-consuming. The machine can also detect retinal detachments, circulation disorders and even signs of diabetes. A session on the OCT and Optomap machines is not part of a routine eye test but is sometimes recommended by opticians if there is a particular concern.
      Read Full Article
    2. Volcano Corporation Announces Webcast of February 25th Analyst Day

      SAN DIEGO, Feb. 20 /- Volcano Corporation (Nasdaq: VOLC ), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, will hold its 2009 Analyst Day on Wednesday, February 25, at the NASDAQ MarketSite in New York City. The webcast will begin at 10 a.m., Eastern Standard Time (7 a.m., Pac...
      Read Full Article
    3. Topcon 3-D Measurement Software Granted FDA Clearance

      Topcon Medical Systems, Inc. (Paramus, NJ), has received FDA clearance for the enhanced 3D OCT-1000 TrueMap Measurement Software as an addition to the previously cleared 3D OCT-1000 Optical Coherence Tomography System, according to a company news release. The software allows users to view four layers of the retina, including the inner limiting membrane, the photoreceptor inner and outer segment junction, retinal pigment epithelium, and Bruch's membrane. In addition, the software is compatible with the Stratus 1 OCT system (Carl Zeiss Meditec, Dublin, CA). The cost of the 3D OCT-1000 TrueMap Measurement Software is included in the cost of the ...
      Read Full Article
    4. Volcano Reports Full Year Revenues Increase 31 Percent

      FOURTH QUARTER REVENUES INCREASE 23 PERCENT SAN DIEGO, Feb. 17 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported that revenues for the full year 2008 increased 31 percent over full year 2007 and that revenues for the fourth quarter of 2008 increased 23 percent over revenues in the fourth quarter of 2007. For the year ended December
      Read Full Article
    5. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast

      SAN DIEGO, Feb. 6 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report is operating results for the fourth quarter and all of fiscal 2008 on Tuesday, February 17. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Stan
      Read Full Article
    6. Michelson Diagnostics issues preliminary specs for clinical handheld OCT probe

      Michelson Diagnostics issues preliminary specs for clinical handheld OCT probe
      JANUARY 26, 2009--Michelson Diagnostics (London, UK) has issued a preliminary specification for its clinical optical coherence tomography (OCT) probe and processing system, which the company demonstrated this past weekend at the SPIE's BiOS exhibition. The system, named Vivosight, will be available with two probe versions--one with X-Y scanning to enable 3D mapping of flat tissue such as skin, and the other with a rigid endoscope for internal applications.
      Read Full Article
    7. Michelson Diagnostics singled out as high-growth company

      Uk-based Michelson Diagnostics has been singled out as a company with high growth potential by two leading investor organisations. The European Tech Tour Association held its first MedTech Tour Summit in November 2008 to bring together Europe’s most innovative medical technology companies with leading venture capitalists and leading industry professionals. Michelson Diagnostics was one of just 24 start-up companies selected from 240 candidates, by an expert panel of investors, to present at the event. The MedTech Tour Summit attracted big name US investors, including Medtronic, Johnson & Johnson, Edwards Lifesciences, and Boston Scientific, as well as US venture capitalists from ...
      Read Full Article
    8. OPKO Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System

      OPKO Health, Inc. OPK today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to begin marketing in the United States its Spectral OCT SLO Combination Imaging System. Currently marketed internationally by the Company’s subsidiary, OPKO Instrumentation, LLC, the Spectral OCT SLO is the product of more than a decade of innovation in the field of combination imaging. High-resolution images are produced with inner retinal choroid and vitreous detail that allow for improved monitoring of ophthalmic disease progression or regression
      Read Full Article
      Mentions: Optos
    9. Topcon granted FDA clearance for OCT measurement software

      Paramus, NJ—Topcon Medical Systems has received FDA clearance for its enhanced 3D optical coherence tomography (OCT) measurement software (OCT-1000 TrueMap) as an addition to its previously cleared OCT system (3D OCT-1000), according to a prepared statement. The software, according to the company, is designed to allow physicians to visualize four layers of the retina: the inner limiting membrane, the IS/OS junction, the retinal pigment epithelium, and Bruch’s membrane. The software also can import and read data from a time-domain OCT device (Stratus, Carl Zeiss Meditec).
      Read Full Article
    10. Volcano Corporation Makes Big Bets on Optical Coherence Tomography: Projects OCT Cardiology & Related Markets At More Than $1B

      Volcano Corporation Makes Big Bets on Optical Coherence Tomography: Projects OCT Cardiology & Related Markets At More Than $1B
      Volcano Corporation, a leading company in the IVUS, seems to be a big believer in the OCT cardiology market and is backing that belief with big bets. Last year Volcano acquired CardioSpectra (a 2 year old startup company out of the University of Texas at Austin) for $63M ($25M plus an additional $38M earn out). See article. More recently Volcano acquired Axsun Technologies (a leading company in micro-optical systems technology) for $21.5M mainly for their high performance compact swept-source laser. See article. A laser their main OCT competitor Lightlab Imaging (a leading company in the OCT space) claimed to ...
      Read Full Article
    11. OCT will be a draw at show

      Zeiss, Grafton, Haag Streit and Topcon will exhibit their latest scanners, which enable practices to provide in-depth pre-screening and clinical care for charges of between £25 and £150 for a four-minute procedure. Andy Yorke, managing director of Topcon said: 'The ability to look beyond the retinal surface into the sub-retinal layers presents us with diagnostic opportunities not seen before and provides the clinician with the ability to detect eye diseases much earlier.'
      Read Full Article
    12. Michelson Diagnostics Release Preliminary Specifications for Clinical Hand-Held OCT Probe

      Michelson Diagnostics Release Preliminary Specifications for Clinical Hand-Held OCT Probe
      Michelson Diagnostics has issued a preliminary specification for its clinical Optical Coherence Tomography (OCT) probe and processing system, which the company says is planned for launch in late spring 2009. The new OCT system has been given the name ‘Vivosight’. Preliminary specifications for the new release can be seen here. Two variants of the new Vivosight probe are specified, one is a version with X-Y scanning, to enable 3D mapping of flat tissue such as skin, and the other is a version equipped with a rigid endoscope, suitable for internal applications. The unique multi-beam design provides double the image resolution ...
      Read Full Article
    13. LightLab's cardiac OCT progress sets stage for new developments

      JANUARY 7, 2009--LightLab Imaging (Westford, MA), producer of optical coherence tomography (OCT) systems for diagnosing and treating heart disease, reports installation of >300 OCT systems in 20 countries, a 45% increase in per-system catheter use, >10,000 imaging procedures performed, and status as "the only reimbursed intravascular OCT imaging product in the world." The company will soon announce a major clinical study in the US.
      Read Full Article
    14. Lightlab Imaging Leads Global Advancement of Intracoronary Imaging

      Finishes 2008 with More Than 300 Systems in 20 Countries and a 45% Increase in Per-System Catheter Utilization. Total OCT Image Procedures Performed Surpass 10,000 Westford, MA, January 5, 2009 -- LightLab Imaging Inc. today announced several important developments in the field this past year that
      Read Full Article
    15. OCT market on track despite recession

      A year ago, Greg Smolka predicted that the market for optical coherence tomography (OCT) would keep growing, passing the $800 million mark by 2012. And then the recession swooped in. Not to worry, says Smolka, vice president of the industrial, military and space business unit at Vectron International in Hudson, N.H. He authored a comprehensive market report on OCT technology titled “Optical Coherence Tomography – Technology, Markets, and Applications: 2008-2012” in February 2008. But he doesn’t think today’s economic downward spiral will kill the OCT market.
      Read Full Article
    16. TopCon 3D OCT-100 Promotion Video

      TopCon 3D OCT-100 Promotion Video
      Andersen Opticians Weybridge. Advice on eye examinations, 3D optical coherence tomography - technology that could save your eyesight, frames, nikon lenses, contact lenses and sunglasses. www.andersenopticians.co.uk. Opticians Walton-on-Thames. www.andersenlenses.co.uk From: hakim1977 Views: 422 0 ratings Time: 05:54 More in Science & Technology
      Read Full Article
    17. Michelson Diagnostics to demonstrate prototype hand-held OCT Probe at BIOS 09

      Michelson Diagnostics to demonstrate prototype hand-held OCT Probe at BIOS 09
      Michelson Diagnostics has announced that it will demonstrate its prototype multi-beam Optical Coherence Tomography (OCT) probe at the BIOS Exhibition at SPIE Photonics West, San Jose, 24-25th January 2009 (Stand 8731). More than one variant of the new probe will be launched later in 2009, including a dermal version (with X-Y scanning, to enable 3D mapping of skin lesions) and a version equipped with a rigid endoscope, suitable for oral applications. "We will be applying for a CE-mark for the product enabling sale for clinical use in Europe, in the spring 2009 time-frame" said Jon Holmes, Chief Executive, "followed by ...
      Read Full Article
    18. Optovue Reaches Milestone with Placement of 1000th RTVue FD-OCT

      FREMONT, Calif., Nov 13, 2008 (BUSINESS WIRE) -- Optovue, a pioneer in optical coherence tomography (OCT), announced that the company has now shipped more than 1000 RTVue(TM) systems worldwide. In just two years since its introduction, RTVue has gained rapid acceptance by leading clinicians around the globe. RTVue is the first and only FDA-cleared spectral domain OCT capable of imaging both the front (cornea) and back (retina) of the eye in a single system. In addition, RTVue offers unprecedented analytical capabilities, allowing physicians to evaluate tissue at greater depths and with more detail than is possible with other commercially available ...
      Read Full Article
    19. Optovue Reaches Milestone with Placement of 1000th RTVue FD-OCT

      FREMONT, Calif.--(BUSINESS WIRE)--Optovue, a pioneer in optical coherence tomography (OCT), announced that the company has now shipped more than 1000 RTVue™ systems worldwide. In just two years since its introduction, RTVue has gained rapid acceptance by leading clinicians around the globe. RTVue is the first and only FDA-cleared spectral domain OCT capable of imaging both the front (cornea) and back (retina) of the eye in a single system. In addition, RTVue offers unprecedented analytical capabilities, allowing physicians to evaluate tissue at greater depths and with more detail than is possible with other commercially available systems. These functions, together ...
      Read Full Article
    20. Michelson Diagnostics Announces New PS1301 Processing System

      Michelson Diagnostics Announces New PS1301 Processing System
      Michelson Diagnostics is pleased to announce the launch of its latest product, the PS1301 four-channel Optical Coherence Tomography (OCT) processing system. It is targeted at research customers who need to build their swept-source OCT experiments quickly, and do not want to use valuable project time
      Read Full Article
    21. Light Sources Demonstrate Low Power Dissipation

      Light Sources Demonstrate Low Power Dissipation
      Functioning over an operating temperature from 10°C to 40°C, EXALOS’ EBS4000-0000 and EBS8000-000 stabilized broadband light sources exhibit power dissipation of ~5 W for each superluminescent LED inside. The 200 mm × 160 mm × 124 mm 2 kg EBS4000-0000 incorporates up to 4 superluminescent LEDs over a single output, and the 200 mm × 290 mm × 124 mm 3 kg EBS8000-0000 integrates up to 8 superluminescent LEDs over up to 8 outputs. The turnkey devices offer input power from 100 VAC to 240 VAC at 50 Hz to 60 Hz, a FC/APC optical connector, a touchscreen, and a painted ...
      Read Full Article
      Mentions: Exalos
    22. Turnkey Devices Incorporate SLED Technology

      Performing in laboratory applications, Exalos’ EBS4000-0000 and EBS8000-0000 turnkey devices with touchscreens enable the use of superluminescent light emitting diode (SLED) technology. The EBS4000-0000 can utilize up to 4 different SLEDs, and the EBS8000-0000 can utilize up to 8 ones with availability as single- or multiple-port optical outputs. The SLEDs offer wavelengths from 650 nm to 1,600 nm and output powers from 1 mW to 25 mW, depending on wavelength. Applications include fiber optic sensing, optical coherence tomography, and optical metrology.
      Read Full Article
      Mentions: Exalos
    937-960 of 1027 « 1 2 ... 37 38 39 40 41 42 43 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (1 articles) FDA
  4. People in the News

    1. (1 articles) Jay Wei
  5. OCT Companies in the News

    1. (1 articles) Notal Vision
    2. (1 articles) Optovue